(Q36517425)

14 August 2017

1 reference

title

Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic (English)

1 reference

14 August 2017

Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic (English)

1 reference

27 October 2022

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679763

27 October 2022

1 reference

27 October 2022

author name string

Palladino MA Jr

9

1 reference

14 August 2017

H. M. Shepard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679763

27 October 2022

G. D. Lewis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679763

27 October 2022

J. C. Sarup

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679763

27 October 2022

B. M. Fendly

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679763

27 October 2022

D. Maneval

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679763

27 October 2022

J. Mordenti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679763

27 October 2022

I. Figari

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679763

27 October 2022

C. E. Kotts

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679763

27 October 2022

M. A. Palladino

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679763

27 October 2022

A. Ullrich

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679763

27 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1679763

27 October 2022

publication date

1 May 1991

1 reference

full work available at URL

14 August 2017

http://link.springer.com/content/pdf/10.1007/BF00918679.pdf

1 reference

http://link.springer.com/article/10.1007/BF00918679/fulltext.html

27 October 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF00918679

27 October 2022

1 reference

Journal of Clinical Immunology

27 October 2022

published in

1 reference

14 August 2017

volume

11

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

117-127

1 reference

p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor

14 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00918679

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

21 January 2018

1 reference

12 December 2020

Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth

1 reference

12 December 2020

Innovations that influence the pharmacology of monoclonal antibody guided tumor targeting

1 reference

12 December 2020

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer

1 reference

12 December 2020

Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer

1 reference

12 December 2020

Anti-EGF receptor monoclonal antibodies: biological studies and potential clinical applications

1 reference

12 December 2020

p185neu expression in human lung adenocarcinomas predicts shortened survival

1 reference

12 December 2020

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

1 reference

12 December 2020

Resistance of tumor cells to tumor necrosis factor

1 reference

12 December 2020

Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages

1 reference

12 December 2020

The molecular genetics of cancer

1 reference

12 December 2020

Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.

1 reference

12 December 2020

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

12 December 2020

Mechanisms of tumor progression

1 reference

12 December 2020

Induction of a variety of tumors by c-erbB2 and clonal nature of lymphomas even with the mutated gene (Val659----Glu659).

1 reference

12 December 2020

Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

Signal transduction by receptors with tyrosine kinase activity

1 reference

12 December 2020

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

1 reference

12 December 2020

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

1 reference

12 December 2020

Resistance of human ovarian cancer cells to tumor necrosis factor and lymphokine-activated killer cells: correlation with expression of HER2/neu oncogenes.

1 reference

12 December 2020

Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression

1 reference

12 December 2020

Growth factor receptor tyrosine kinases

1 reference

12 December 2020

Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells

1 reference

12 December 2020

Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2.

1 reference

12 December 2020

Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase acti

1 reference

12 December 2020

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells

1 reference

12 December 2020

Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product

1 reference

12 December 2020

Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer

1 reference

12 December 2020

Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice

1 reference

12 December 2020

Viruses, oncogenes, and cancer.

1 reference

12 December 2020

Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00918679

1 reference

14 August 2017

1 reference